Leaderboard
Anzeige
Fr
|
De
Feedback
|
Impressum
|
Sitemap
Aucun choix d'articles!
Panier
Vous êtes ici:
Recherche de documentation spécialisée
»
Œsophage
»
Néoplasie
19. Août 2026
Recherche
Gastroplattform
Néoplasie
Recherche avancée
Dépistage / diagnostic
Traitements
Directives
Perfectionnement
Nouvelles
Recherche de documentation spécialisée
Voies biliaires
Foie
Estomac / intestins
Œsophage
Troubles de la motilité
Néoplasie
Autres
Pancréas
Congrès et sessions
Services et outils
Liens
Rect Top
Anzeige
Écriture:
Page 1 de 1976
Articles 1 - 20 / 39519
Development and validation of machine learning-based rapid plan model for radiotherapy treatment of esophageal cancer.
J Cancer Res Ther
Sanju S, Choubey A, Chakraborty T, Kataria A, Barman S, Saini V, Kumar N, Nanda SS, Mukherji A, Pradhan S.
PMID: 42617023 [PubMed - indexed for MEDLINE]
Correlation of health-related quality of life with dose to dysphagia aspiration-related structures in head and neck cancer patients treated with intensity-modulated radiotherapy.
J Cancer Res Ther
Saini G, Hari S, Shukla R, Arora S.
PMID: 42617014 [PubMed - indexed for MEDLINE]
ASO Visual Abstract: Robotic Versus Laparoscopic Gastrectomy for Advanced Gastric Cancer: Prognostic Implications of Surgical Recovery and Oncologic Control in a Propensity Score-Matched Study.
Ann Surg Oncol
Komatsu S, Konishi T, Ohashi T, Nagamori H, Ogawa S, Matsumoto Y, Fujita Y, Matsuo H, Kuriu Y, Ikoma H, Okamoto K, Otsuji E, Shiozaki A.
PMID: 42616320 [PubMed - as supplied by publisher]
[Personalized systemic treatment of metastatic esophageal cancer].
Chirurgie (Heidelb)
Lordick F, Predel L, Jenke R, Stocker G, Gebauer J, Hacker U.
PMID: 42616054 [PubMed - as supplied by publisher]
Deep learning models based on CT predict prognosis in patients with locally advanced esophageal squamous cell carcinoma who received neoadjuvant immunotherapy and chemotherapy.
Front Immunol
Zhao J, Yuan Z, Shi H, Li Y, Li C, Zhang R, Liu C.
PMID: 42614303 [PubMed - indexed for MEDLINE]
Age-Period-Cohort Analysis and Projections of Smoking-Attributable Upper Gastrointestinal Cancers Burden: A Comparative Study of China and the World.
Cancer Med
Li Y, Guo Y, Wang MP, Li WQ, Leung WK.
PMID: 42613585 [PubMed - indexed for MEDLINE]
FOLFOX in Esophageal Squamous Cell Carcinoma: Current Evidence and Future Role as a Cisplatin-Sparing Chemoimmunotherapy Backbone.
J Gastrointest Cancer
Sagawa T, Nagashima H, Fujikawa K.
PMID: 42611109 [PubMed - indexed for MEDLINE]
Current Status and Future Perspectives of Robotic Surgery for Esophagogastric Cancer in Asia.
Ann Gastroenterol Surg
Ang JJ, So JBY.
PMID: 42609754 [PubMed - as supplied by publisher]
Circulating Sex Hormone Levels and Survival in Men With Esophageal Squamous Cell Carcinoma.
Cancer Med
Liu Z, Lin Z, Lagergren J, Wang H, Mao X, Ma M, Hu Z, Xie SH.
PMID: 42608898 [PubMed - indexed for MEDLINE]
Timing of immune checkpoint inhibitor infusion predicts survival in advanced esophageal squamous cell carcinoma: A retrospective cohort study.
Ther Adv Med Oncol
Wang W, Fan C, Shen L, Ni R, Ye L, Mao W, Hong W, Xu X.
PMID: 42605279 [PubMed]
Y Chromosome Haplogroups and Susceptibility to Esophageal Squamous Cell Carcinoma: An Exploratory Association and Diagnostic Modeling Study.
Mol Genet Genomic Med
Shi X, Wang N, Zhou W, Zhong H, Liu T, Song M, Zhou Y, Song X.
PMID: 42605118 [PubMed - indexed for MEDLINE]
Salvage Surgery After Proton Beam-Based Chemoradiotherapy for Esophageal Squamous Cell Carcinoma: A Case Series Study.
Ann Surg Oncol
Kakinuma H, Honda M, Hori S, Yamamoto R, Nishino K, Takagawa Y, Suzuki N, Takano Y.
PMID: 42603834 [PubMed - as supplied by publisher]
Analysis of real-world clinical outcomes of perioperative chemotherapy compared to preoperative chemoradiotherapy in esophagogastric adenocarcinoma.
Cancer
Oyenuga M, Goyal S, Hannan LM, Emiloju O, Dosunmu GT, Miao R, Gbolahan O, Russell M, Lin J, Switchenko JM, Alese OB.
PMID: 42603143 [PubMed - indexed for MEDLINE]
Advocating for Precision Neoadjuvant and Subsequent Adjuvant Therapies in Esophageal Squamous Cell Carcinoma: Evidence From a Real-World Multicenter Study.
MedComm (2020)
Wang P, Wei X, Yu Y, Zhao Z, Ge Q, Lian J, Xing W, Li X, Li Y.
PMID: 42602445 [PubMed]
Verrucous carcinoma diagnosed via surgical resection in a patient with recurrent esophageal obstruction: a rare case report with 12 year follow-up.
Clin J Gastroenterol
Takaori K, Iwagami H, Matsumoto H.
PMID: 42601551 [PubMed - as supplied by publisher]
Association between ABO blood group and survival in patients with esophageal, gastric, and colorectal cancer: a systematic review and meta-analysis.
Eur J Cancer Prev
Schena S, Nuvoli L, De Pascale S, Romario UF, Sileo A, Doccioli C, Di Maggio E, Palmieri G, La Vecchia C, Caini S, Gandini S.
PMID: 42598881 [PubMed - as supplied by publisher]
Immune exhaustion in esophageal cancer: interferon pathway dysregulation and neoadjuvant therapy response.
Front Cell Dev Biol
Wu X, Gao S, Qi Y.
PMID: 42597607 [PubMed]
Association of TyG-BMI and malnutrition with reduced survival outcomes in patients with cancer: a prospective study.
Front Nutr
Gong YZ, Zhang BM, Liao C, Zhu LC, Ruan GT.
PMID: 42597479 [PubMed]
Harnessing the quinoline core for targeted cancer therapy.
Future Med Chem
Liu CJ, Huang WW, Wang JJ, Jiang WS, Zhang XY, Chen X, Gao Y, Dai XJ.
PMID: 42593423 [PubMed - as supplied by publisher]
Garcinoic acid promotes ferroptosis-associated growth inhibition in esophageal squamous cell carcinoma through an MDM2-associated mechanism.
Transl Cancer Res
Sun LY, Huang P, Su YH.
PMID: 42591837 [PubMed]
Articles 1 - 20 / 39519
Page 1 de 1976
Rect Bottom
Anzeige
Adserver Footer
Intervalle de temps demandé
--sans limitation--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy
|
Publicité